Studienliteratur zu den Hepatoblastomen

Erstellt am 03.06.2013, Zuletzt geändert: 18.08.2021

Studienliteratur Hepatoblastome


  1. Ritz A, Kolorz J, Hubertus J, Ley-Zaporozhan J, von Schweinitz D, Koletzko S, Häberle B, Schmid I, Kappler R, Berger M, Lurz E: Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma. Pediatric blood & cancer 2021, 68:e28862 [PMID: 33438330] RIT2021
  2. Wagner AE, Schwarzmayr T, Häberle B, Vokuhl C, Schmid I, Kaller M, Hermeking H, von Schweinitz D, Kappler R: Erratum: Wagner, A. E, et al. SP8 Promotes an Aggressive Phenotype in Hepatoblastoma via FGF8 Activation. Cancers 2020, 12, 2294. Cancers 2021, 13 [PMID: 33498595] WAG2021
  3. Regel I, Eichenmüller M, Mahajan UM, Hagl B, Benitz S, Häberle B, Vokuhl C, von Schweinitz D, Kappler R: Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations. Journal of cancer research and clinical oncology 2020, 146: 1153 [PMID: 32189106] REG2020
  4. Haeberle B, Rangaswami A, Krailo M, Czauderna P, Hiyama E, Maibach R, Lopez-Terrada D, Aronson DC, Alaggio R, Ansari M, Malogolowkin MH, Perilongo G, O'Neill AF, Trobaugh-Lotrario AD, Watanabe K, Schmid I, von Schweinitz D, Ranganathan S, Yoshimura K, Hishiki T, Tanaka Y, Piao J, Feng Y, Rinaldi E, Saraceno D, Derosa M, Meyers RL: The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database. Pediatric blood & cancer 2020, 67:e28350 [PMID: 32383794] HAE2020
  5. Weiss JBW, Wagner AE, Eberherr C, Häberle B, Vokuhl C, von Schweinitz D, Kappler R: High expression of IGF2-derived intronic miR-483 predicts outcome in hepatoblastoma. Cancer biomarkers 2020, 28: 321 [PMID: 32390604] WEI2020
  6. Cairo S, Armengol C, Maibach R, Häberle B, Becker K, Carrillo-Reixach J, Guettier C, Vokuhl C, Schmid I, Buendia MA, Branchereau S, von Schweinitz D, Kappler R: A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients. European journal of cancer (Oxford, England : 1990) 2020, 141: 30 [PMID: 33125945] CAI2020
  7. Eberherr C, Beck A, Vokuhl C, Becker K, Häberle B, Von Schweinitz D, Kappler R: Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells. International journal of oncology 2019, 54: 1853 [PMID: 30864675] EBE2019
  8. Beck A, Trippel F, Wagner A, Joppien S, Felle M, Vokuhl C, Schwarzmayr T, Strom TM, von Schweinitz D, Längst G, Kappler R: Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma. Clinical epigenetics 2018, 10: 27 [PMID: 29507645] BEC2018
  9. Schmid I, von Schweinitz D: Pediatric hepatocellular carcinoma: challenges and solutions. Journal of hepatocellular carcinoma 2017, 4: 15 [PMID: 28144610] SCH2017c
  10. Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P: Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration. The Lancet 2017, 18: 122 [PMID: 27884679] MEY2017
  11. Beck A, Eberherr C, Hagemann M, Cairo S, Häberle B, Vokuhl C, von Schweinitz D, Kappler R: Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma. Cancer biology & therapy 2016, 17: 1168 [PMID: 27635950] BEC2016
  12. Gödeke J, Luxenburger E, Trippel F, Becker K, Häberle B, Müller-Höcker J, von Schweinitz D, Kappler R: Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma. Hepatology international 2016, 10: 370 [PMID: 26646663] GOE2016
  13. Czauderna P, Haeberle B, Hiyama E, Rangaswami A, Krailo M, Maibach R, Rinaldi E, Feng Y, Aronson D, Malogolowkin M, Yoshimura K, Leuschner I, Lopez-Terrada D, Hishiki T, Perilongo G, von Schweinitz D, Schmid I, Watanabe K, Derosa M, Meyers R: The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. European journal of cancer 2016, 52: 92 [PMID: 26655560] CZA2016
  14. Vokuhl C, Oyen F, Häberle B, von Schweinitz D, Schneppenheim R, Leuschner I: Small Cell Undifferentiated Hepatoblastomas (SCUD): All Malignant Rhabdoid Tumors? Genes, chromosomes & cancer 2016, [PMID: 27356182] VOK2016
  15. Ilmer M, Garnier A, Vykoukal J, Alt E, von Schweinitz D, Kappler R, Berger M: Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma. Molecular cancer therapeutics 2015, 14: 2712 [PMID: 26516161] IIM2015
  16. Becker K, Furch C, Schmid I, von Schweinitz D, Häberle B: Impact of postoperative complications on overall survival of patients with hepatoblastoma. Pediatric blood & cancer 2015, 62: 24 [PMID: 25251521] BEC2015
  17. Trobaugh-Lotrario AD, Chaiyachati BH, Meyers RL, Häberle B, Tomlinson GE, Katzenstein HM, Malogolowkin MH, von Schweinitz D, Krailo M, Feusner JH: Outcomes for patients with congenital hepatoblastoma. Pediatric blood & cancer 2013, epub ahead of print [PMID: 23798361] TRO2013
  18. Schmid I, Häberle B, Albert MH, Corbacioglu S, Fröhlich B, Graf N, Kammer B, Kontny U, Leuschner I, Scheel-Walter HG, Scheurlen W, Werner S, Wiesel T, von Schweinitz D: Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma. Pediatric blood & cancer 2012, 58: 539 [PMID: 21922643] SCH2012c
  19. von Schweinitz D: Hepatoblastoma: recent developments in research and treatment. Seminars in pediatric surgery 2012, 21: 21 [PMID: 22248967] SCH2012b
  20. Kappler R, von Schweinitz D: A better way forward: targeting hedgehog signaling in liver cancer. Frontiers in bioscience 2012, 4: 277 [PMID: 22202060] KAP2012
  21. Goedeke J, Haeberle B, Schmid I, von Schweinitz D: 30. AFP Negative Cystic Liver Lesion in a Child Should Let One Think of Hepatoblastoma. J Pediatr Hematol Oncol 2011, 33:e245 [PMID: 21383638 ] GOE2011
  22. Grotegut S, Kappler R, Tarimoradi S, Lehembre F, Christofori G, Von Schweinitz D: Hepatocyte growth factor protects hepatoblastoma cells from chemotherapy-induced apoptosis by AKT activation. International journal of oncology 2010, 36: 1261 [PMID: 20372801] GRO2010
  23. Eichenmüller M, Gruner I, Hagl B, Häberle B, Müller-Höcker J, von Schweinitz D, Kappler R: Blocking the hedgehog pathway inhibits hepatoblastoma growth. Hepatology 2009, 49: 482 [PMID: 19177589] EIC2009a
  24. Hartmann W, Küchler J, Koch A, Friedrichs N, Waha A, Endl E, Czerwitzki J, Metzger D, Steiner S, Wurst P, Leuschner I, von Schweinitz D, Buettner R, Pietsch T: Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival. Clinical cancer research 2009, 15: 4538 [PMID: 19584164] HAR2009
  25. Eichenmüller M, von Schweinitz D, Kappler R: Betulinic acid treatment promotes apoptosis in hepatoblastoma cells. International journal of oncology 2009, 35: 873 [PMID: 19724925] EIC2009
  26. Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G: Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. Journal of clinical oncology 2010, 28: 2584 [PMID: 20406943] ZSI2007
  27. Koch A, Waha A, Hartmann W, Hrychyk A, Schuller U, Waha A, Wharton KA Jr, Fuchs SY, von Schweinitz D, Pietsch T: Elevated expression of Wnt antagonists is a common event in hepatoblastomas. Clinical cancer research 2005, 11: 4295 [PMID: 15958610] KOC2005
  28. Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R, Perilongo G, Shafford E, Plaschkes J, International Society of Pediatric Oncology (SIOP): Otte JB, Pritchard J, Aronson DC, et al.: Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004, 42: 74-83. [PMID: 14752798] OTT2004
  29. Koch A, Weber N, Waha A, Hartmann W, Denkhaus D, Behrens J, Birchmeier W, von Schweinitz D, Pietsch T: Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas. The Journal of pathology 2004, 204: 546 [PMID: 15538750] KOC2004
  30. Albrecht S, Hartmann W, Houshdaran F, Koch A, Gartner B, Prawitt D, Zabel BU, Russo P, Von Schweinitz D, Pietsch T: Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15. 5 in hepatoblastoma. International journal of cancer. Journal international du cancer 2004, 111: 627 [PMID: 15239143] ALB2004